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hypocellular, with decreased chondrocyte number. BrdU incorpora-
tion assays and immunohistochemical staining for proliferating cell
nuclear antigen (PCNA) showed a marked reduction in replicating
cells in mutant mice. In addition, proliferation assays revealed de-
creased chondrocyte numbers from mutant mice in culture, which
is rescued by NO donor treatments (DATA-NO and SNAP). Organ
culture of tibiae from E15.5 eNos mutant mice demonstrates re-
duced bone growth and chondrocyte proliferation compared with
the wild type littermates, suggesting that the role of eNOS sig-
naling in chondrocyte proliferation is cell-autonomous. Reduced
chondrocyte number may in part be due to premature cell-cycle
exit because of decreased cyclin D1 and increased p57 expression
in mutants. Additional, reactive oxygen species were increased in
mutant chondrocytes as indicated by a ﬂuorescent dye (DCFH), in
parallel to increased apoptosis as indicated by increased staining
for cleaved caspase-3. Mutant mice also demonstrated increased
total and phosphorylated p38 and GSK-3β, reduced total and
phosphorylated Akt, and decreased SOX9 expression.
Conclusions: In summary, these data identify an essential role
of eNOS in chondrocyte proliferation, endochondral bone growth
and demonstrate that the eNOS gene regulates the coordination
between cell-cycle exit and chondrocyte differentiation in cartilage.
191
ESE-1 REGULATES MMP13 EXPRESSION IN
CHONDROCYTES
M. Otero1, D.A. Plumb1, C. Dragomir1, K. Tsuchimochi1,
J. Chen1, D. Gluck1, P. Roman1, J. Harkess1, L. Xu2, Y. Li2,
M.B. Goldring1
1Hosp. for Special Surgery, New York, NY; 2Harvard Sch. of
Dental Med., Boston, MA
Purpose: Matrix metalloproteinase (MMP)-13 plays a major role in
osteoarthritis (OA) due to its-rate limiting role in collagen degrada-
tion. MMP-13 expression is regulated by a variety of transcription
factors including ESE-1, a member of the E26 transformation-
speciﬁc sequence (ETS) family. ESE-1 is induced by inﬂammatory
cytokines and is expressed in OA chondrocytes, where it represses
type II collagen promoter activity. The aim of this study was to
determine whether ESE-1 participates in MMP-13 transcriptional
regulation in chondrocytes.
Methods: The binding of in vitro-translated ESE-1 to the MMP-
13 promoter was analyzed by electrophoretic mobility shift as-
say (EMSA) and supershift analysis. To analyze the response of
the MMP-13 promoter to ESE-1, luciferase reporter assays were
performed using cell extracts of C-28/I2 and T/C-28a2 cells co-
transfected with constructs of the human MMP-13 promoter and
expression vectors encoding ESE-1, Runx2, cFos and cJun. For
knockdown of ESE-1 expression, human primary chondrocytes
and human immortalized chondrocytes were transfected with a
pool of four individual siRNA oligonucleotides against ESE-1 or
control nonspeciﬁc siRNA. After incubation for 96 h, the knock-
down was conﬁrmed by real time PCR and Western blotting,
and MMP-13 mRNA was analyzed by real time PCR. ESE-1 and
MMP-13 protein levels and type II collagen cleavage products
were addressed by immunohistochemical staining in human OA
cartilage, cho/+ mouse cartilage and Ese1 -/- mouse cartilage
specimens.
Results: Immunohistochemical analysis revealed increased ESE-
1 levels in both human and mouse OA cartilage specimens, and
ESE-1 co-localization with MMP-13 protein and type II collagen
cleavage products. EMSA and supershift analysis detected speciﬁc
binding of ESE-1 to three ETS sites in the proximal MMP-13
promoter. Luciferase reporter assays showed that ESE-1 over-
expression leads to the MMP-13 promoter activation in synergism
with Runx2 and AP-1 (cFos/cJun). Deletion of the sequences
containing the ESE-1 binding sites blocked activity. Real time
PCR analysis revealed lower MMP-13 basal mRNA expression
associated with ESE-1 knockdown and signiﬁcant reduction of IL-
1-induced MMP-13 mRNA levels. Immunohistochemical analysis
of cartilage from Ese1 -/- mice revealed low or undetectable
MMP-13 protein levels compared to wild type mice.
Conclusions: Our results in chondrocyte cultures suggest that
this transcription factor participates in the cytokine-induced activa-
tion of MMP-13 gene expression, as well as in the maintenance of
basal expression. Moreover, our ﬁnding that increased ESE-1 lev-
els in OA cartilage correlate with increased MMP-13 protein and
type II collagen cleavage products highlights its involvement in car-
tilage catabolic processes. Indeed, we are currently investigating
the relative contribution of ESE-1 absence to the OA onset and
progression in mouse OA models. Finally, the decreased MMP-13
protein levels in the cartilage of Ese1 -/- mice further reinforces the
role of the ESE-1 in homeostatic cartilage remodeling. Altogether,
our results show that ESE-1 is a key regulator of MMP-13 gene
expression in chondrocytes.
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Purpose: The aim of this study was to identify the type of death
that chondrocytes undergo and to correlate it with changes in
the endoplasmic reticulum (ER) and Golgi complex in the three
zones of the cartilage during Osteoarthritis (OA) pathogenesis in
an experimental model.
Methods: The experimentally OA-induced model was accom-
plished by unilateral knee menisectomy and post-surgery training;
normal rats were used as a control. Animals were sacriﬁced by
CO2 overdose and right femoral condyles were removed and
processed for either electron microscopy (EM) or Immunohisto-
chemistry (IHC). Chondrocytes death was identiﬁed with TUNEL
and IHC for cleaved caspase 3 active and LC3II in cartilage from
rats with 5, 10, 20 and 45 training days (td). At the same time
development of ER and G membranes were monitored with mark-
ers to calnexin and 58k-9 protein respectively. EM was used as a
complementary methodology to identify ER, Golgi complex (at 5
td) and autophagic vacuoles (20 td) in OA cartilage.
Results: Cell death analysis showed that throughout early stages
of OA, chondrocytes death started by apoptosis in the superﬁcial
(SZ) and middle zones (MZ) of the cartilage. As the degenerative
process progressed, autophagy began to be evident in the SZ.
Finally, in late stages of OA, chondrocytes co-expressed both
death markers in the SZ and MZ; while in the deep zone (DZ), just
apoptosis was discernible. In agreement with cell death processes,
ER and Golgi complex suffered changes during the ﬁrst 5 td and
showed a prominent ER with dilated cisterns and enhanced Golgi
complex membranes; in late stages of OA these changes were
maintained especially in the SZ and MZ.
Conclusions: Our results suggest that during the OA pathogene-
sis, chondrocytes undergo changes to increase their synthetic as
well as catabolic activities at early stages and late stages of OA
respectively. Afterward, at late stages of OA, when chondrocytes
repair capacity is overwhelm, they activate its own program of
cellular death, which includes autophagy, apoptosis and changes
in ER and G, characteristics of chondroptosis.
